---
title: Determine how balance affects sleep
nct_id: NCT07424924
status: RECRUITING
sponsor: Biruni University
study_type: OBSERVATIONAL
canonical_url: "https://parkinsonspathways.com/trial/NCT07424924"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT07424924"
last_fetched: "2026-05-10T14:02:20.416Z"
source: "Parkinson's Pathways (curated)"
---
# Determine how balance affects sleep

**Goal (in five words):** Determine how balance affects sleep

**Official Title:** The Relationship Between Balance and Gait Impairments, Physical Activity Level, and Sleep Quality in Parkinson's Disease

**Trial ID:** [NCT07424924](https://clinicaltrials.gov/study/NCT07424924)

## Key Facts

- **Status:** RECRUITING
- **Study Type:** OBSERVATIONAL
- **Sponsor:** Biruni University
- **Target Enrollment:** 34 participants
- **Start Date:** 2026-01-05
- **Completion Date:** 2026-03-05
- **Conditions:** Parkinson Disease

## Summary For Families

The team wants to understand how balance and walking problems in Parkinson's relate to daily physical activity and sleep quality, because those connections can influence falls, fatigue, and overall function. Participants with Parkinson's and matched healthy volunteers will have balance and gait tested and their activity and sleep tracked using clinical assessments and smartphone-based monitoring to find patterns between mobility, activity level, and sleep. No treatment is given; Parkinson's participants should be Hoehn and Yahr stages 1 to 3, able to walk independently, on a stable medication plan, and tested while in their "on" phase. The study is looking for adults 40 to 75 years old who use a smartphone and do not have major other neurological, cardiovascular, orthopedic, hearing, or vision problems.

## Eligibility

- **Minimum age:** 40 Years
- **Maximum age:** 75 Years
- **Sex:** ALL

### Full Criteria

```
Inclusion Criteria:

For Patients with Parkinson's Disease:

A confirmed diagnosis of Parkinson's disease according to the United Kingdom (UK) Brain Bank Criteria and classified as Hoehn and Yahr stages 1-3

Ability to walk independently on a flat surface without assistive devices (Functional Ambulation Scale ≥3)

Stable medication regimen during the past month

Being in the "on" phase of medication

For Healthy Individuals:

No diagnosis of neurological and/or neurodegenerative disease

Exclusion Criteria:

(For both Parkinson's patients and healthy individuals)

Severe hearing or visual impairments

Presence of other neurological, cardiovascular, or orthopedic conditions that may affect walking ability

Any additional neurological disorder (e.g., dementia, cerebrovascular disease)

Education level less than 5 years

Vascular pathologies affecting the lower extremities

Lack of smartphone use
```

## Locations (1)

- Biruni University Hospital, Istanbul, Turkey (Türkiye) _(41.0138, 28.9497)_

## Central Contacts

- Güzin Kaya Aytutuldu, phd — (CONTACT) — 05366265884 — guzinkaya14@gmail.com

---

*Canonical: https://parkinsonspathways.com/trial/NCT07424924*  
*HTML version: https://parkinsonspathways.com/trial/NCT07424924*  
*Source data: https://clinicaltrials.gov/study/NCT07424924*